当前位置: 首页 > 期刊 > 《特别健康.下半月》 > 2014年第10期 > 正文
编号:12806431
再生障碍性贫血患者血清中细胞因子水平及临床意义(2)
http://www.100md.com 2014年10月1日 周峰等
第1页

    参见附件。

     [4]Young N.S.Acquired aplastic anemia [J]. Ann Intern Med, 2002.136(7): 534-546.

    [5]储榆林,张之南,杨天楹,郝玉书.再生障碍性贫血[A]. 血液病学,北京:人民卫生出版社 2003;618-634.

    [6]Cluitmans FH, Esendam BH, Veenhof WF, et al.The role of cytokines and hematopoietic growth factors in the autocrine/paracrine regulation of inducible hematopoiesis [J]. Ann Hematol, 1997. 75(1-2): 27-31.

    [7]陈志伟,张际绯,许惠玉。血细胞发生和调控学概论[A]. 北京:人民卫生出版社, 2008:116-117.

    [8]Gear AR and CameriniD. Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense [J]. Microcirculation, 2003.10(3-4):335-350.

    [9]Feng X, Scheinberg P, Samsel L, et al.Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura [J]. ThrombHaemost, 2012. 10(8): 1616-1623.

    [10]Feng X,Scheinberg P, Wu CO, et al.Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes [J]. Haematologica,2010. 96(4): 602-606.

    [11]Kilroy GE, Foster SJ, Wu X, et al. Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors [J]. J Cell Physiol, 2007.212(3): 702-709.

您现在查看是摘要介绍页,详见PDF附件